BRIEF published on 01/27/2025 at 17:50, 10 months 8 days ago Ateme 2025 Financial Calendar Financial Calendar General Meeting Quarterly Results ATEME Financial Publications
PRESS RELEASE published on 01/27/2025 at 17:45, 10 months 8 days ago 2025 FINANCIAL CALENDAR Ateme (ISIN: FR0011992700) announces its financial communication agenda for 2025, including key publication dates. Learn about the global leader in video compression solutions Financial Communication ATEME Video Compression Publication Dates 2025 Agenda
BRIEF published on 01/10/2025 at 17:50, 10 months 25 days ago Half-yearly report of the Ateme Liquidity Contract as of December 31, 2024 Liquidity Contract Kepler Cheuvreux Half-yearly Report ATEME Stock Market Transactions
PRESS RELEASE published on 01/10/2025 at 17:45, 10 months 25 days ago HALF-YEAR LIQUIDITY CONTRACT STATEMENT AT DECEMBER 31, 2024 Ateme and Kepler Cheuvreux provide details of the liquidity contract resources for Ateme's shares as of December 31st, 2024, in accordance with AMF Decision N°2021-01 Liquidity Contract Shares Kepler Cheuvreux AMF Decision ATEME
BRIEF published on 10/17/2024 at 17:50, 1 year 1 month ago ATEME: Growth in the 3rd quarter of 2024 Growth EMEA Turnover Recurring Income United States/Canada
PRESS RELEASE published on 10/17/2024 at 17:45, 1 year 1 month ago ACTIVITY FOR THE THIRD QUARTER AND THE FIRST NINE MONTHS OF 2024 Ateme's Q3 2024 revenues rise by 10%, US/Canada region grows by 18%. Monthly Recurring Revenue up 18% year-on-year. Benoit Fouchard joins Executive Committee Revenues Executive Committee Growth Q3 2024 ATEME
BRIEF published on 09/30/2024 at 10:05, 1 year 2 months ago Availability of Ateme's 2024 half-year financial report Investors AMF Financial Report Consolidated Accounts ATEME
BRIEF published on 09/26/2024 at 17:50, 1 year 2 months ago Ateme's 2024 half-year results and update of financial objectives Financial Results EBITDA Turnover Véronique Coulmann 2027 Objectives
PRESS RELEASE published on 09/26/2024 at 17:50, 1 year 2 months ago FIRST HALF 2024 RESULTS AND UPDATED GUIDANCE Ateme reports 17% revenue decrease, appoints new CFO, aims for €4M MRR and €22M EBITDA in 2027. Operating costs cut by €1.6M in H1 2024 CFO Appointment Revenue Decrease ATEME 2027 Financial Objectives Operating Costs Reduction
BRIEF published on 07/11/2024 at 17:50, 1 year 4 months ago ATEME: Activity for the 2nd quarter and first half of 2024 Growth EMEA Turnover United States OTT
Published on 12/05/2025 at 02:35, 4 hours 36 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 11 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 6 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 11 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 11 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 41 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 20 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 46 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 56 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 11 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 26 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 27 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
